Tubulointerstitial nephritis and uveitis syndrome
ICD-10 N10; H20.9 · ICD-11 9A96.1

Treatment of TINU Syndrome in Bilateral, Intermediate, or Posterior Uveitis

Tubulointerstitial nephritis and uveitis syndrome (TINU) requires tailored management based on the pattern and laterality of uveitis involvement. This protocol addresses the clinical scenario of bilateral uveitis, intermediate uveitis, or posterior uveitis — presentations where the choice of treatment route is clinically consequential.

Clinical Scenario

Bilateral, intermediate, or posterior uveitis in the context of TINU syndrome — a presentation pattern that typically mandates a systemic rather than purely local therapeutic approach.

Treatment Approach

Systemic corticosteroid therapy is the cornerstone of management for this presentation.

The complete protocol — including sequencing, adjunctive options, and individualised considerations — is available below.

Treatment Goal

Prompt resolution of ocular inflammation.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1097/ICU.0b013e3283318f9a

In bilateral, intermediate, or posterior disease, systemic corticosteroids are typically required with the option for local steroid injections reserved for the rare unilateral case.

Ocular inflammation and renal function respond promptly to corticosteroid treatment during active disease, but maintaining quiescence in the eye can be more difficult than in the kidney.

View source ↗